BACKGROUND: Capsule endoscopy is a widely performed procedure for small bowel investigation. Once swallowed by the patient, the capsule transmits images to an external recorder over a digital radiofrequency communication channel. Potential electromagnetic interferences with implantable cardiac devices have been postulated. Clinical studies on the safety of capsule endoscopy in patients with cardiac defibrillators are lacking. OBJECTIVE: The aim of this study was to assess potential mutual electromagnetic interferences between capsule and defibrillators. METHODS: This study used the Given M2A video capsule system. Ten different types of defibrillators were tested in a clinical setting. Before capsule ingestion, defibrillator electrical therapies were switched off. During capsule endoscopy patients were monitored with cardiac telemetry. At the end of capsule endoscopy the following defibrillator's parameters were analysed: change in device settings; inappropriate shocks; inappropriate anti-tachycardia therapy; inappropriate sensing or pacing; noise detection; device reset; programming changes; permanent electrical damages. Any technical problem related to capsule image transmission was recorded. RESULTS: Neither defibrillator malfunction nor interference in sensing or pacing was recorded; conversely, no capsule malfunction potentially caused by defibrillators was registered. CONCLUSION: Our results suggest that capsule endoscopy can be safely performed in patients with cardiac defibrillators.
BACKGROUND: Capsule endoscopy is a widely performed procedure for small bowel investigation. Once swallowed by the patient, the capsule transmits images to an external recorder over a digital radiofrequency communication channel. Potential electromagnetic interferences with implantable cardiac devices have been postulated. Clinical studies on the safety of capsule endoscopy in patients with cardiac defibrillators are lacking. OBJECTIVE: The aim of this study was to assess potential mutual electromagnetic interferences between capsule and defibrillators. METHODS: This study used the Given M2A video capsule system. Ten different types of defibrillators were tested in a clinical setting. Before capsule ingestion, defibrillator electrical therapies were switched off. During capsule endoscopy patients were monitored with cardiac telemetry. At the end of capsule endoscopy the following defibrillator's parameters were analysed: change in device settings; inappropriate shocks; inappropriate anti-tachycardia therapy; inappropriate sensing or pacing; noise detection; device reset; programming changes; permanent electrical damages. Any technical problem related to capsule image transmission was recorded. RESULTS: Neither defibrillator malfunction nor interference in sensing or pacing was recorded; conversely, no capsule malfunction potentially caused by defibrillators was registered. CONCLUSION: Our results suggest that capsule endoscopy can be safely performed in patients with cardiac defibrillators.
Authors: Gregory G Ginsberg; Alan N Barkun; John J Bosco; Gerard A Isenberg; Cuong Cao Nguyen; Bret T Petersen; William B Silverman; Adam Slivka; Greta Taitelbaum Journal: Gastrointest Endosc Date: 2002-11 Impact factor: 9.427
Authors: Bret T Petersen; Nadeem Hussain; Joseph E Marine; Richard G Trohman; Steven Carpenter; Ram Chuttani; Joseph Croffie; James Disario; Poonputt Chotiprasidhi; Julia Liu; Lehel Somogyi Journal: Gastrointest Endosc Date: 2007-04 Impact factor: 9.427
Authors: Dirk Bandorski; Erich Lotterer; Dirk Hartmann; Ralf Jakobs; Martin Brück; Reinhard Hoeltgen; Marcus Wieczorek; Alexander Brock; Thomas de Rossi; Martin Keuchel Journal: J Gastrointestin Liver Dis Date: 2011-03 Impact factor: 2.008
Authors: Jonathan A Leighton; Komandoor Srivathsan; Elizabeth J Carey; Virender K Sharma; Russell I Heigh; Janice K Post; Paula J Erickson; Sarah R Robinson; Jane L Bazzell; David E Fleischer Journal: Am J Gastroenterol Date: 2005-08 Impact factor: 10.864